Literature DB >> 21060015

Functional impact of white matter hyperintensities in cognitively normal elderly subjects.

Melissa E Murray1, Matthew L Senjem, Ronald C Petersen, John H Hollman, Greg M Preboske, Stephen D Weigand, David S Knopman, Tanis J Ferman, Dennis W Dickson, Clifford R Jack.   

Abstract

OBJECTIVE: To investigate the impact white matter hyperintensities (WMH) detected on magnetic resonance imaging have on motor dysfunction and cognitive impairment in elderly subjects without dementia.
DESIGN: Cross-sectional study.
SETTING: Population-based study on the incidence and prevalence of cognitive impairment in Olmsted County, Minnesota. PARTICIPANTS: A total of 148 elderly subjects (65 men) without dementia ranging in age from 73 to 91 years. MAIN OUTCOME MEASURES: We measured the percentage of the total white matter volume classified as WMH in a priori-defined brain regions (ie, frontal, temporal, parietal, occipital, periventricular, or subcortical). Motor impairment was evaluated qualitatively using the Unified Parkinson's Disease Rating Scale summary measures of motor skills and quantitatively using a digitized portable walkway system. Four cognitive domains were evaluated using z scores of memory, language, executive function, and visuospatial reasoning.
RESULTS: A higher WMH proportion in all regions except the occipital lobe was associated with lower executive function z score (P value <.01). A higher WMH proportion in all regions, but most strongly for the parietal lobe, correlated with higher Unified Parkinson's Disease Rating Scale gait, posture, and postural stability sum (P value <.01). A higher WMH proportion, whether periventricular, subcortical, or lobar, correlated with reduced velocity (P value <.001).
CONCLUSIONS: We conclude that executive function is the primary cognitive domain affected by WMH burden. The data suggest that WMH in the parietal lobe are chiefly responsible for reduced balance and postural support compared with the other 3 lobes and may alter integration of sensory information via parietal lobe dysfunction in the aging brain. Parietal white matter changes were not the predominant correlate with motor speed, lending evidence to a global involvement of neural networks in gait velocity.

Entities:  

Mesh:

Year:  2010        PMID: 21060015      PMCID: PMC3025610          DOI: 10.1001/archneurol.2010.280

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  23 in total

1.  Unified segmentation.

Authors:  John Ashburner; Karl J Friston
Journal:  Neuroimage       Date:  2005-04-01       Impact factor: 6.556

2.  Progression of white matter hyperintensities in elderly individuals over 3 years.

Authors:  Perminder Sachdev; Wei Wen; Xiaohua Chen; Henry Brodaty
Journal:  Neurology       Date:  2007-01-16       Impact factor: 9.910

3.  White matter hyperintensities are related to physical disability and poor motor function.

Authors:  P S Sachdev; W Wen; H Christensen; A F Jorm
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

4.  Accrual of MRI white matter abnormalities in elderly with normal and impaired mobility.

Authors:  Leslie Wolfson; Xingchang Wei; Charles B Hall; Victoria Panzer; Dorothy Wakefield; Randall R Benson; Julia A Schmidt; Simon K Warfield; Charles R G Guttmann
Journal:  J Neurol Sci       Date:  2005-05-15       Impact factor: 3.181

Review 5.  Neurological gait disorders in elderly people: clinical approach and classification.

Authors:  Anke H Snijders; Bart P van de Warrenburg; Nir Giladi; Bastiaan R Bloem
Journal:  Lancet Neurol       Date:  2007-01       Impact factor: 44.182

6.  Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study.

Authors:  M M Breteler; N M van Amerongen; J C van Swieten; J J Claus; D E Grobbee; J van Gijn; A Hofman; F van Harskamp
Journal:  Stroke       Date:  1994-06       Impact factor: 7.914

7.  Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline.

Authors:  L C Silbert; C Nelson; D B Howieson; M M Moore; J A Kaye
Journal:  Neurology       Date:  2008-07-08       Impact factor: 9.910

8.  Rating impairment and disability in Parkinson's disease: evaluation of the Unified Parkinson's Disease Rating Scale.

Authors:  J J van Hilten; A D van der Zwan; A H Zwinderman; R A Roos
Journal:  Mov Disord       Date:  1994-01       Impact factor: 10.338

9.  Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies.

Authors:  Prashanthi Vemuri; Jeffrey L Gunter; Matthew L Senjem; Jennifer L Whitwell; Kejal Kantarci; David S Knopman; Bradley F Boeve; Ronald C Petersen; Clifford R Jack
Journal:  Neuroimage       Date:  2007-10-22       Impact factor: 6.556

10.  The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics.

Authors:  Rosebud O Roberts; Yonas E Geda; David S Knopman; Ruth H Cha; V Shane Pankratz; Bradley F Boeve; Robert J Ivnik; Eric G Tangalos; Ronald C Petersen; Walter A Rocca
Journal:  Neuroepidemiology       Date:  2008-02-07       Impact factor: 3.282

View more
  65 in total

Review 1.  The declining infrastructure of the aging brain.

Authors:  David H Salat
Journal:  Brain Connect       Date:  2011

Review 2.  The contribution of white matter lesions to Parkinson's disease motor and gait symptoms: a critical review of the literature.

Authors:  Branislav Veselý; Angelo Antonini; Ivan Rektor
Journal:  J Neural Transm (Vienna)       Date:  2015-10-19       Impact factor: 3.575

3.  The effect of interference on temporal order memory for random and fixed sequences in nondemented older adults.

Authors:  Jerlyn C Tolentino; Eva Pirogovsky; Trinh Luu; Chelsea K Toner; Paul E Gilbert
Journal:  Learn Mem       Date:  2012-05-21       Impact factor: 2.460

4.  Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease.

Authors:  Nicolaas I Bohnen; Martijn L T M Müller; Natalia Zarzhevsky; Robert A Koeppe; Christopher W Bogan; Michael R Kilbourn; Kirk A Frey; Roger L Albin
Journal:  Brain       Date:  2011-06-08       Impact factor: 13.501

5.  Physical activity, motor function, and white matter hyperintensity burden in healthy older adults.

Authors:  Debra A Fleischman; Jingyun Yang; Konstantinos Arfanakis; Zoe Arvanitakis; Sue E Leurgans; Arlener D Turner; Lisa L Barnes; David A Bennett; Aron S Buchman
Journal:  Neurology       Date:  2015-03-11       Impact factor: 9.910

6.  Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study.

Authors:  David S Knopman; Michael E Griswold; Seth T Lirette; Rebecca F Gottesman; Kejal Kantarci; A Richey Sharrett; Clifford R Jack; Jonathan Graff-Radford; Andrea L C Schneider; B Gwen Windham; Laura H Coker; Marilyn S Albert; Thomas H Mosley
Journal:  Stroke       Date:  2015-01-06       Impact factor: 7.914

7.  A quantitative postmortem MRI design sensitive to white matter hyperintensity differences and their relationship with underlying pathology.

Authors:  Melissa E Murray; Prashanthi Vemuri; Greg M Preboske; Matthew C Murphy; Katherine J Schweitzer; Joseph E Parisi; Clifford R Jack; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2012-12       Impact factor: 3.685

8.  Concomitant pathologies among a spectrum of parkinsonian disorders.

Authors:  Brittany N Dugger; Charles H Adler; Holly A Shill; John Caviness; Sandra Jacobson; Erika Driver-Dunckley; Thomas G Beach
Journal:  Parkinsonism Relat Disord       Date:  2014-02-22       Impact factor: 4.891

Review 9.  Vascular parkinsonism--characteristics, pathogenesis and treatment.

Authors:  Amos D Korczyn
Journal:  Nat Rev Neurol       Date:  2015-04-28       Impact factor: 42.937

10.  Effects of white matter lesions on trunk stability during dual-task walking among older adults with mild cognitive impairment.

Authors:  Takehiko Doi; Hiroyuki Shimada; Hyuma Makizako; Kota Tsutsumimoto; Ryo Hotta; Sho Nakakubo; Takao Suzuki
Journal:  Age (Dordr)       Date:  2015-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.